Faculty Listing By Sites

Michelle A Albert, MD, MPH
M_MED-CORE-CARD
Professor




Michelle A. Albert is a Professor in Medicine at the University of California at San Francisco (UCSF) and director of the CeNter for the StUdy of AdveRsiTy and CardiovascUlaR DiseasE (NURTURE Research Center). She was the Vivian Beaumont Allen Endowed Professor/Chair and Chief of Cardiology at Howard University. Albert is a graduate of Haverford College, University of Rochester School of Medicine, Harvard School of Public Health, and completed Internal Medicine Residency and was also Chief Resident in Medicine at Columbia University. Dr. Albert then completed Cardiovascular Clinical and Research Fellowship at the Brigham and Women's Hospital and Harvard Medical School, where she rose in the ranks to an Associate Professor in Medicine.
Her clinical expertise involves taking care of the most critically ill advanced heart disease patients, and preventive cardiology with a focus on vulnerable populations. From a research perspective, her research has followed a non-traditional, but bold path for cardiovascular disease (CVD) research -- first characterizing the predictive capability of novel inflammatory and thrombotic biomarkers of CVD risk at the population level, to identifying how noted relationships vary by important social and demographic characteristics, and now to defining the mechanisms of differential cardiovascular disease risk across the life-course in children, older populations, women and racial/ethnic minorities exposed to adversity, i.e "the biology of adversity".
She was Vice-President and Board Member of the Association of Black Cardiologists (ABC), a member of the National Academy of Sciences Committee on Qualification of Biomarkers and Surrogate Endpoints in Chronic Disease and serves as a reviewer for multiple journals including currently as Associate Editor at Atherosclerosis, Thrombosis & Vascular Biology (ATVB), a member of the Editorial Board of Circulation and as Section Editor for Current Cardiovascular Risk Reports. Dr Albert is also a member of the Association of University Cardiologists. She served/s on several national committees of the American College of Cardiology (ACC) and American Heart Association (AHA) including as a member of the Epidemiology Council, the AHA National Research Committee, Executive Committee-Clinical Cardiology Council, SACC, AHA Executive Database Steering Committee (Chair), Sarnoff Foundation Scientific Board and is a current Board Member and is President-Elect, AHA San Francisco/Bay Area Board.
A recipient of multiple research awards, including multi-million dollar R01 funding from the NIH and funding from RWJ, Kellogg and Doris Duke Foundations, Dr. Albert enjoys mentoring trainees at all levels across the United States and was nominated for the competitive 2011-2012 Excellence in Mentoring Award at Harvard Medical School. She is a recipient of Woman's Day Magazine's Red Dress Award (2014), received the Haverford College Alumni Award (2015) and is the recipient of the 2016 Women in Cardiology Mentoring Award from the AHA. She is one of two recipients of the prestigious 2018 AHA Merit award for visionary research.

Awards and Honors

2018   Merit Award, American Heart Association, 2018
2016   Women in Cardiology Mentoring Award, American Heart Association, 2016
2016   Elected Member, Association of University Cardiologists, 2016
2015   The Haverford Award, recognizing an alumnus who uses their knowledge to the benefit of society, Haverford College, 2015
2014   Featured "Editor's Choice & Scientist": MA Health Care Reform, Race/Ethnicity and CVD, Circulation Journal (June 17, 2014), 2014
2014   Red Dress Award Honoree, Women's Day Magazine, 2014
2012   Second Annual Heart of Women's Health CREDO Award, American College of Cardiology, 2012
2010   Nesson Fellowship Award, Brigham and Women’s Hospital, Boston MA, 2010
2006   J Ira and Nikki Harris Family Research Award, Brigham and Women's Hospital, Boston MA, 2006
2004   Herbert W. Nickens Epidemiology Award, Association of Black Cardiologists, Inc, 2004
2003   Learner Young Investigator Award,, Brigham and Women’s Hospital, Boston MA, 2003
2001   Brigham and Women's Hospital/Kraft Minority Faculty Development Award, Brigham and Women’s Hospital, Boston MA, 2001

Related Web Sites

In the News

Recent Articles (50)

  1. Albert MA. #Me_Who: Anatomy of Scholastic, Leadership, and Social Isolation of Underrepresented Minority Women in Academic Medicine. Circulation. 2018 May 22.

  2. Powell-Wiley TM, Ngwa J, Kebede S, Lu D, Schulte PJ, Bhatt DL, Yancy C, Fonarow GC, Albert MA. Impact of Body Mass Index on Heart Failure by Race/Ethnicity From the Get With The Guidelines-Heart Failure (GWTG-HF) Registry. JACC Heart Fail. 2018 Mar; 6(3):233-242.

  3. Carnethon MR, Pu J, Howard G, Albert MA, Anderson CAM, Bertoni AG, Mujahid MS, Palaniappan L, Taylor HA, Willis M, Yancy CW. Cardiovascular Health in African Americans: A Scientific Statement From the American Heart Association. Circulation. 2017 Nov 21; 136(21):e393-e423.

  4. Albert MA, Durazo EM, Slopen N, Zaslavsky AM, Buring JE, Silva T, Chasman D, Williams DR. Cumulative psychological stress and cardiovascular disease risk in middle aged and older women: Rationale, design, and baseline characteristics. Am Heart J. 2017 Oct; 192:1-12.

  5. Cuevas AG, Williams DR, Albert MA. Psychosocial Factors and Hypertension: A Review of the Literature. Cardiol Clin. 2017 May; 35(2):223-230.

  6. Slopen N, Chen Y, Guida JL, Albert MA, Williams DR. Positive childhood experiences and ideal cardiovascular health in midlife: Associations and mediators. Prev Med. 2017 Apr; 97:72-79.

  7. Hira RS, Bhatt DL, Fonarow GC, Heidenreich PA, Ju C, Virani SS, Bozkurt B, Petersen LA, Hernandez AF, Schwamm LH, Eapen ZJ, Albert MA, Liang L, Matsouaka RA, Peterson ED, Jneid H. Temporal Trends in Care and Outcomes of Patients Receiving Fibrinolytic Therapy Compared to Primary Percutaneous Coronary Intervention: Insights From the Get With The Guidelines Coronary Artery Disease (GWTG-CAD) Registry. J Am Heart Assoc. 2016 Oct 06; 5(10).

  8. Cozier YC, Albert MA, Castro-Webb N, Coogan PF, Ridker P, Kaufman HW, Palmer JR, Rosenberg L. Neighborhood Socioeconomic Status in Relation to Serum Biomarkers in the Black Women's Health Study. J Urban Health. 2016 Apr; 93(2):279-91.

  9. Slopen N, Chen Y, Priest N, Albert MA, Williams DR. Emotional and instrumental support during childhood and biological dysregulation in midlife. Prev Med. 2016 Mar; 84:90-6.

  10. Slopen N, Shonkoff JP, Albert MA, Yoshikawa H, Jacobs A, Stoltz R, Williams DR. Racial Disparities in Child Adversity in the U.S.: Interactions With Family Immigration History and Income. Am J Prev Med. 2016 Jan; 50(1):47-56.

  11. Slopen N, Non A, Williams DR, Roberts AL, Albert MA. Childhood adversity, adult neighborhood context, and cumulative biological risk for chronic diseases in adulthood. Psychosom Med. 2014 Sep; 76(7):481-9.

  12. Albert MA, Ayanian JZ, Silbaugh TS, Lovett A, Resnic F, Jacobs A, Normand SL. Early results of Massachusetts healthcare reform on racial, ethnic, and socioeconomic disparities in cardiovascular care. Circulation. 2014 Jun 17; 129(24):2528-38.

  13. Redmond N, Richman J, Gamboa CM, Albert MA, Sims M, Durant RW, Glasser SP, Safford MM. Perceived stress is associated with incident coronary heart disease and all-cause mortality in low- but not high-income participants in the Reasons for Geographic And Racial Differences in Stroke study. J Am Heart Assoc. 2013 Dec 19; 2(6):e000447.

  14. Albert MA. Not there yet: Medicare Part D and elimination of cardiovascular medication usage sociodemographic disparities after myocardial infarction. Circulation. 2014 Feb 18; 129(7):723-4.

  15. Slopen N, Kontos EZ, Ryff CD, Ayanian JZ, Albert MA, Williams DR. Psychosocial stress and cigarette smoking persistence, cessation, and relapse over 9-10 years: a prospective study of middle-aged adults in the United States. Cancer Causes Control. 2013 Oct; 24(10):1849-63.

  16. Plitt A, Dorbala S, Albert MA, Giugliano RP. Cardiac sarcoidosis: case report, workup, and review of the literature. Cardiol Ther. 2013 Dec; 2(2):181-97.

  17. Clark CR, Ommerborn MJ, Hickson DA, Grooms KN, Sims M, Taylor HA, Albert MA. Neighborhood disadvantage, neighborhood safety and cardiometabolic risk factors in African Americans: biosocial associations in the Jackson Heart study. PLoS One. 2013; 8(5):e63254.

  18. Mosca L, Hammond G, Mochari-Greenberger H, Towfighi A, Albert MA. Fifteen-year trends in awareness of heart disease in women: results of a 2012 American Heart Association national survey. Circulation. 2013 Mar 19; 127(11):1254-63, e1-29.

  19. Powell-Wiley TM, Ayers CR, de Lemos JA, Lakoski SG, Vega GL, Grundy S, Das SR, Banks-Richard K, Albert MA. Relationship between perceptions about neighborhood environment and prevalent obesity: data from the Dallas Heart Study. Obesity (Silver Spring). 2013 Jan; 21(1):E14-21.

  20. Slopen N, Glynn RJ, Buring JE, Lewis TT, Williams DR, Albert MA. Job strain, job insecurity, and incident cardiovascular disease in the Women's Health Study: results from a 10-year prospective study. PLoS One. 2012; 7(7):e40512.

  21. Slopen N, Dutra LM, Williams DR, Mujahid MS, Lewis TT, Bennett GG, Ryff CD, Albert MA. Psychosocial stressors and cigarette smoking among African American adults in midlife. Nicotine Tob Res. 2012 Oct; 14(10):1161-9.

  22. Lee TC, Glynn RJ, Peña JM, Paynter NP, Conen D, Ridker PM, Pradhan AD, Buring JE, Albert MA. Socioeconomic status and incident type 2 diabetes mellitus: data from the Women's Health Study. PLoS One. 2011; 6(12):e27670.

  23. Albert MA. Biomarkers and heart disease. J Clin Sleep Med. 2011 Oct 15; 7(5 Suppl):S9-11.

  24. Manson JE, Bassuk SS, Lee IM, Cook NR, Albert MA, Gordon D, Zaharris E, Macfadyen JG, Danielson E, Lin J, Zhang SM, Buring JE. The VITamin D and OmegA-3 TriaL (VITAL): rationale and design of a large randomized controlled trial of vitamin D and marine omega-3 fatty acid supplements for the primary prevention of cancer and cardiovascular disease. Contemp Clin Trials. 2012 Jan; 33(1):159-71.

  25. Albert MA, Glynn RJ, Fonseca FA, Lorenzatti AJ, Ferdinand KC, MacFadyen JG, Ridker PM. Race, ethnicity, and the efficacy of rosuvastatin in primary prevention: the Justification for the Use of Statins in Prevention: an Intervention Trial Evaluating Rosuvastatin (JUPITER) trial. Am Heart J. 2011 Jul; 162(1):106-14.e2.

  26. Albert MA, Williams DR. Invited commentary: Discrimination--an emerging target for reducing risk of cardiovascular disease? Am J Epidemiol. 2011 Jun 01; 173(11):1240-3.

  27. Powell TM, de Lemos JA, Banks K, Ayers CR, Rohatgi A, Khera A, McGuire DK, Berry JD, Albert MA, Vega GL, Grundy SM, Das SR. Body size misperception: a novel determinant in the obesity epidemic. Arch Intern Med. 2010 Oct 11; 170(18):1695-7.

  28. Moukarbel GV, Albert MA. The ecology of stent thrombosis: a view from a sociobiological perspective. Circulation. 2010 Sep 14; 122(11):1053-5.

  29. Albert MA. Receipt of high-quality coronary heart disease care in the United States: all about being black or white: comment on "Racial differences in admissions to high-quality hospitals for coronary heart disease". Arch Intern Med. 2010 Jul 26; 170(14):1216-7.

  30. Slopen N, Lewis TT, Gruenewald TL, Mujahid MS, Ryff CD, Albert MA, Williams DR. Early life adversity and inflammation in African Americans and whites in the midlife in the United States survey. Psychosom Med. 2010 Sep; 72(7):694-701.

  31. Albert MA, Cozier Y, Ridker PM, Palmer JR, Glynn RJ, Rose L, Halevy N, Rosenberg L. Perceptions of race/ethnic discrimination in relation to mortality among Black women: results from the Black Women's Health Study. Arch Intern Med. 2010 May 24; 170(10):896-904.

  32. Cook NR, Albert MA. Regarding REGARDS: Does inflammation explain racial and regional differences in cardiovascular disease risk? Clin Chem. 2009 Sep; 55(9):1603-5.

  33. Albert MA, Pare G, Morris A, Rose L, Buring J, Ridker PM, Zee RY. Candidate genetic variants in the fibrinogen, methylenetetrahydrofolate reductase, and intercellular adhesion molecule-1 genes and plasma levels of fibrinogen, homocysteine, and intercellular adhesion molecule-1 among various race/ethnic groups: data from the Women's Genome Health Study. Am Heart J. 2009 Apr; 157(4):777-83.e1.

  34. Conen D, Glynn RJ, Ridker PM, Buring JE, Albert MA. Socioeconomic status, blood pressure progression, and incident hypertension in a prospective cohort of female health professionals. Eur Heart J. 2009 Jun; 30(11):1378-84.

  35. Albert MA. Heart failure in the urban African enclave of Soweto: a case study of contemporary epidemiological transition in the developing world. Circulation. 2008 Dec 02; 118(23):2323-5.

  36. Albert MA, Ravenell J, Glynn RJ, Khera A, Halevy N, de Lemos JA. Cardiovascular risk indicators and perceived race/ethnic discrimination in the Dallas Heart Study. Am Heart J. 2008 Dec; 156(6):1103-9.

  37. Albert MA. Race/ethnicity and inflammation: is there a link to periodontal disease? J Periodontol. 2008 Jul; 79(7):1121-3.

  38. Albert MA. Inflammatory biomarkers, race/ethnicity and cardiovascular disease. Nutr Rev. 2007 Dec; 65(12 Pt 2):S234-8.

  39. Albert MA, Glynn RJ, Buring JE, Ridker PM. Differential effect of soluble intercellular adhesion molecule-1 on the progression of atherosclerosis as compared to arterial thrombosis: a prospective analysis of the Women's Health Study. Atherosclerosis. 2008 Mar; 197(1):297-302.

  40. Albert MA, Glynn RJ, Buring JE, Ridker PM. Relation between soluble intercellular adhesion molecule-1, homocysteine, and fibrinogen levels and race/ethnicity in women without cardiovascular disease. Am J Cardiol. 2007 May 01; 99(9):1246-51.

  41. Albert MA, Glynn RJ, Buring J, Ridker PM. Impact of traditional and novel risk factors on the relationship between socioeconomic status and incident cardiovascular events. Circulation. 2006 Dec 12; 114(24):2619-26.

  42. Albert MA, Ridker PM. C-reactive protein as a risk predictor: do race/ethnicity and gender make a difference? Circulation. 2006 Aug 01; 114(5):e67-74.

  43. Albert MA, Glynn RJ, Wolfert RL, Ridker PM. The effect of statin therapy on lipoprotein associated phospholipase A2 levels. Atherosclerosis. 2005 Sep; 182(1):193-8.

  44. Albert MA, Torres J, Glynn RJ, Ridker PM. Perspective on selected issues in cardiovascular disease research with a focus on black Americans. Circulation. 2004 Jul 13; 110(2):e7-12.

  45. Albert MA, Glynn RJ, Buring J, Ridker PM. C-reactive protein levels among women of various ethnic groups living in the United States (from the Women's Health Study). Am J Cardiol. 2004 May 15; 93(10):1238-42.

  46. Albert MA, Glynn RJ, Ridker PM. Effect of physical activity on serum C-reactive protein. Am J Cardiol. 2004 Jan 15; 93(2):221-5.

  47. Albert MA, Ridker PM. Inflammatory biomarkers in African Americans: a potential link to accelerated atherosclerosis. Rev Cardiovasc Med. 2004; 5 Suppl 3:S22-7.

  48. Blake GJ, Albert MA, Rifai N, Ridker PM. Effect of pravastatin on LDL particle concentration as determined by NMR spectroscopy: a substudy of a randomized placebo controlled trial. Eur Heart J. 2003 Oct; 24(20):1843-7.

  49. Albert MA, Glynn RJ, Ridker PM. Plasma concentration of C-reactive protein and the calculated Framingham Coronary Heart Disease Risk Score. Circulation. 2003 Jul 15; 108(2):161-5.

  50. Albert MA, Glynn RJ, Ridker PM. Alcohol consumption and plasma concentration of C-reactive protein. Circulation. 2003 Jan 28; 107(3):443-7.

  Select data provided by UCSF Profiles, powered by CTSI at UCSF. Learn more about the data source.